The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects

Title
The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects
Authors
Keywords
Erlotinib, Pharmacokinetics, Rifampicin, CYP3A4, Dose adjustment
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 73, Issue 3, Pages 613-621
Publisher
Springer Nature
Online
2014-01-28
DOI
10.1007/s00280-014-2390-3

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation